Felix Wilhelm Feldhaus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Felix Wilhelm Feldhaus has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Georg Böning
Department of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353 Berlin, Germany
4 shared publications - Uli Fehrenbach
Department of Radiology, Charité – Universitätsmedizin Berlin, Berlin, Germany
4 shared publications - Konrad Neumann
Institute of Biometry and Clinical Epidemiology, Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität zu Berlin, 10117 Berlin, Germany
3 shared publications Diane Renz
Department of Radiology, University of Jena, Jena, Germany
2 shared publications- Felix Doellinger
Department of Radiology, Charité–Universitätsmedizin Berlin, Berlin, Germany
2 shared publications - Florian Streitparth
Department of Radiology, Charite, Humboldt-University, Berlin, Germany
2 shared publications
Latest Publications
- 30 March 2023
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 62 (02) , 155
Einfluss der Ga68-FAPI-46 PET/CT auf die Radiochemotherapie beim lokal rezidivierten oder irresektablen Adenokarzinom des Pankreas
Ziel/Aim Die Fibroblast Activation Protein Inhibitor (FAPI-46) PET/CT ist eine neue Bildgebungsmodalität zum Staging von duktalen Adenokarzinomen des Pankreas (PDAC). Diese Arbeit untersucht den Einfluss der FAPI-46 PET/CT vor geplanter, volumetrisch modulierter image guided radiotherapy (IGRT) mit Capecitabin-basierter Chemotherapie bei irresektablem oder lokal rezidiviertem PDAC. Methodik/Methods Konsekutiver, retrospektiver Einschluss von PatientInnen mit PDAC vor IGRT, mit inoperablem oder lokal rezidiviertem PDAC und stable disease nach Systemtherapie. Als Staging erfolgte eine KM-CT- oder MRT-Untersuchung sowie zusätzlich eine FAPI-46 PET/CT-Untersuchung. Das Staging erfolgte verblindet, jeweils durch einen fachkundigen Radiologen und Nuklearmediziner. Die IGRT wurde durch einen Strahlentherapeuten festgelegt. Bei divergenten Befunden erfolgte eine Biopsie oder Follow-Up Bildgebung. Ergebnisse/Results Bisher konnten 15 Pat. (6w, 9m, 42-80a) eingeschlossen werden. Zwischen KM-CT (n=10) / MRT (n=5) und FAPI-46-PET/CT lagen im Median 33d. Die FAPI-46 PET/CT änderte bei 5/15 (33%) Pat. das therapeutische Vorgehen. Bei 4/15 (27%) Pat. lieferte die FAPI-46 PET/CT zusätzliche Befunde (lymphonodale, hepatische, ossäre Metastasierung, Peritonealkarzinose, Dünndarminfiltration). Eine Biopsie erfolgte bei einer FAPI-46 positiven, atypisch lokalisierten solitären zervikalen LK-Metastase und bestätigte PDAC. Bei 3/15 (20%) wurde eine Radiatio aufgrund der FAPI-46 PET/CT somit nicht durchgeführt. Bei 2/15 Pat. (13%) kam es durch die FAPI-46 PET/CT zu einem Downstaging; die im CT vorbeschriebenen peripankreatischen LK-Metastasen waren FAPI-46 negativ und zeigten keine Größenprogredienz in der Verlaufskontrolle. Bei 2/15 (13%) Pat. ergab sich eine Änderung des Bestrahlungsfeldes. Schlussfolgerungen/Conclusions Die vorläufigen Ergebnisse zeigen einen zusätzlichen Nutzen der FAPI-46 PET/CT in der prätherapeutischen Bildgebung vor Radiochemotherapie bei PDAC. Bei 5/15 (33%) Pat. kam es zu einer Änderung des therapeutischen Vorgehens. Article published online: 30 March 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 30 March 2023
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 62 (02) , 155
Einfluss der Ga68-FAPI-46 PET/CT auf die Radiochemotherapie beim lokal rezidivierten oder irresektablen Adenokarzinom des Pankreas
Ziel/Aim Die Fibroblast Activation Protein Inhibitor (FAPI-46) PET/CT ist eine neue Bildgebungsmodalität zum Staging von duktalen Adenokarzinomen des Pankreas (PDAC). Diese Arbeit untersucht den Einfluss der FAPI-46 PET/CT vor geplanter, volumetrisch modulierter image guided radiotherapy (IGRT) mit Capecitabin-basierter Chemotherapie bei irresektablem oder lokal rezidiviertem PDAC. Methodik/Methods Konsekutiver, retrospektiver Einschluss von PatientInnen mit PDAC vor IGRT, mit inoperablem oder lokal rezidiviertem PDAC und stable disease nach Systemtherapie. Als Staging erfolgte eine KM-CT- oder MRT-Untersuchung sowie zusätzlich eine FAPI-46 PET/CT-Untersuchung. Das Staging erfolgte verblindet, jeweils durch einen fachkundigen Radiologen und Nuklearmediziner. Die IGRT wurde durch einen Strahlentherapeuten festgelegt. Bei divergenten Befunden erfolgte eine Biopsie oder Follow-Up Bildgebung. Ergebnisse/Results Bisher konnten 15 Pat. (6w, 9m, 42-80a) eingeschlossen werden. Zwischen KM-CT (n=10) / MRT (n=5) und FAPI-46-PET/CT lagen im Median 33d. Die FAPI-46 PET/CT änderte bei 5/15 (33%) Pat. das therapeutische Vorgehen. Bei 4/15 (27%) Pat. lieferte die FAPI-46 PET/CT zusätzliche Befunde (lymphonodale, hepatische, ossäre Metastasierung, Peritonealkarzinose, Dünndarminfiltration). Eine Biopsie erfolgte bei einer FAPI-46 positiven, atypisch lokalisierten solitären zervikalen LK-Metastase und bestätigte PDAC. Bei 3/15 (20%) wurde eine Radiatio aufgrund der FAPI-46 PET/CT somit nicht durchgeführt. Bei 2/15 Pat. (13%) kam es durch die FAPI-46 PET/CT zu einem Downstaging; die im CT vorbeschriebenen peripankreatischen LK-Metastasen waren FAPI-46 negativ und zeigten keine Größenprogredienz in der Verlaufskontrolle. Bei 2/15 (13%) Pat. ergab sich eine Änderung des Bestrahlungsfeldes. Schlussfolgerungen/Conclusions Die vorläufigen Ergebnisse zeigen einen zusätzlichen Nutzen der FAPI-46 PET/CT in der prätherapeutischen Bildgebung vor Radiochemotherapie bei PDAC. Bei 5/15 (33%) Pat. kam es zu einer Änderung des therapeutischen Vorgehens. Article published online: 30 March 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score
Radioembolization (RE) is a viable therapy option in patients with intrahepatic cholangiocarcinoma (ICC). This study delineates a prognostic score regarding overall survival (OS) after RE using routine pre-therapeutic parameters. A retrospective analysis of 39 patients (median age, 61 [range, 32–82] years; 26 females, 13 males) with ICC and 42 RE procedures was conducted. Cox regression for OS included age, ECOG, hepatic and extrahepatic tumor burden, thrombosis of the portal vein, ascites, laboratory parameters and dose reduction due to hepatopulmonary shunt. Median OS after RE was 8.0 months. Using univariable Cox, ECOG ≥ 1 (hazard ratio [HR], 3.8), AST/ALT quotient (HR, 1.86), high GGT (HR, 1.002), high CA19-9 (HR, 1.00) and dose reduction of 40% (HR, 3.8) predicted shorter OS (each p < 0.05). High albumin predicted longer OS (HR, 0.927; p = 0.045). Multivariable Cox confirmed GGT ≥ 750 [U/L] (HR, 7.84; p < 0.001), ECOG > 1 (HR, 3.76; p = 0.021), albumin ≤ 41.1 [g/L] (HR, 3.02; p = 0.006) as a three-point pre-therapeutic prognostic score. More specifically, median OS decreased from 15.3 months (0 risk factors) to 7.6 months (1 factor) or 1.8 months (≥2 factors; p < 0.001). The proposed score may aid in improved pre-therapeutic patient identification with (un-)favorable OS after RE and facilitate the balance between potential life prolongation and overaggressive patient selection.
Open AccessTransarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score
Radioembolization (RE) is a viable therapy option in patients with intrahepatic cholangiocarcinoma (ICC). This study delineates a prognostic score regarding overall survival (OS) after RE using routine pre-therapeutic parameters. A retrospective analysis of 39 patients (median age, 61 [range, 32–82] years; 26 females, 13 males) with ICC and 42 RE procedures was conducted. Cox regression for OS included age, ECOG, hepatic and extrahepatic tumor burden, thrombosis of the portal vein, ascites, laboratory parameters and dose reduction due to hepatopulmonary shunt. Median OS after RE was 8.0 months. Using univariable Cox, ECOG ≥ 1 (hazard ratio [HR], 3.8), AST/ALT quotient (HR, 1.86), high GGT (HR, 1.002), high CA19-9 (HR, 1.00) and dose reduction of 40% (HR, 3.8) predicted shorter OS (each p < 0.05). High albumin predicted longer OS (HR, 0.927; p = 0.045). Multivariable Cox confirmed GGT ≥ 750 [U/L] (HR, 7.84; p < 0.001), ECOG > 1 (HR, 3.76; p = 0.021), albumin ≤ 41.1 [g/L] (HR, 3.02; p = 0.006) as a three-point pre-therapeutic prognostic score. More specifically, median OS decreased from 15.3 months (0 risk factors) to 7.6 months (1 factor) or 1.8 months (≥2 factors; p < 0.001). The proposed score may aid in improved pre-therapeutic patient identification with (un-)favorable OS after RE and facilitate the balance between potential life prolongation and overaggressive patient selection.
- Open Access
- 11 October 2022
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 2553-2566
When Treatment of Pulmonary Emphysema with Endobronchial Valves Did Not Work: Evaluation of Quantitative CT Analysis and Pulmonary Function Tests Before and After Valve Explantation
Purpose: To investigate changes in quantitative CT analysis (QCT) and pulmonary function tests (PFT) in pulmonary emphysema patients who required premature removal of endobronchial valves (EBV). Patients and Methods: Our hospital’s medical records listed 274 patients with high-grade COPD (GOLD stages 3 and 4) and pulmonary emphysema who were treated with EBV to reduce lung volume. Prior to intervention, a complete evaluation was performed that included quantitative computed tomography analysis (QCT) of scans acquired at full inspiration and full expiration, pulmonary function tests (PFT), and paraclinical findings (6-minute walking distance test (6MWDT) and quality of life questionnaires). In 41 of these 274 patients, EBV treatment was unsuccessful and the valves had to be removed for various reasons. A total of 10 of these 41 patients ventured a second attempt at EBV therapy and underwent complete reevaluation. In our retrospective study, results from three time points were compared: Before EBV implantation (BL), after EBV implantation (TP2), and after EBV explantation (TP3). QCT parameters included lung volume, total emphysema score (TES, ie, the emphysema index) and the 15th percentile of lung attenuation (P15) for the whole lung and each lobe separately. Differences in these parameters between inspiration and expiration were calculated (Vol. Diff (%), TES Diff (%), P15 Diff (%)). The results of PFT and further clinical tests were taken from the patient’s records. Results: We found persistent therapy effect in the target lobe even after valve explantation together with a compensatory hyperinflation of the rest of the lung. As a result of these two divergent effects, the volume of the total lung remained rather constant. Furthermore, there was a slight deterioration of the emphysema score for the whole lung, whereas the TES of the target lobe persistently improved. Conclusion: Interestingly, we found evidence that, contrary to our expectations, unsuccessful EBV therapy can have a persistent positive effect on target lobe QCT scores.
- 11 October 2022
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 2553-2566
Open AccessWhen Treatment of Pulmonary Emphysema with Endobronchial Valves Did Not Work: Evaluation of Quantitative CT Analysis and Pulmonary Function Tests Before and After Valve Explantation
Purpose: To investigate changes in quantitative CT analysis (QCT) and pulmonary function tests (PFT) in pulmonary emphysema patients who required premature removal of endobronchial valves (EBV). Patients and Methods: Our hospital’s medical records listed 274 patients with high-grade COPD (GOLD stages 3 and 4) and pulmonary emphysema who were treated with EBV to reduce lung volume. Prior to intervention, a complete evaluation was performed that included quantitative computed tomography analysis (QCT) of scans acquired at full inspiration and full expiration, pulmonary function tests (PFT), and paraclinical findings (6-minute walking distance test (6MWDT) and quality of life questionnaires). In 41 of these 274 patients, EBV treatment was unsuccessful and the valves had to be removed for various reasons. A total of 10 of these 41 patients ventured a second attempt at EBV therapy and underwent complete reevaluation. In our retrospective study, results from three time points were compared: Before EBV implantation (BL), after EBV implantation (TP2), and after EBV explantation (TP3). QCT parameters included lung volume, total emphysema score (TES, ie, the emphysema index) and the 15th percentile of lung attenuation (P15) for the whole lung and each lobe separately. Differences in these parameters between inspiration and expiration were calculated (Vol. Diff (%), TES Diff (%), P15 Diff (%)). The results of PFT and further clinical tests were taken from the patient’s records. Results: We found persistent therapy effect in the target lobe even after valve explantation together with a compensatory hyperinflation of the rest of the lung. As a result of these two divergent effects, the volume of the total lung remained rather constant. Furthermore, there was a slight deterioration of the emphysema score for the whole lung, whereas the TES of the target lobe persistently improved. Conclusion: Interestingly, we found evidence that, contrary to our expectations, unsuccessful EBV therapy can have a persistent positive effect on target lobe QCT scores.
- Open Access
- 25 August 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (9) , 1539
Spectral CT Hybrid Images in the Diagnostic Evaluation of Hypervascular Abdominal Tumors—Potential Advantages in Clinical Routine
Background: This study aimed to investigate the use of spectral computed tomography (SCT) hybrid images combining virtual monoenergetic images (VMIs) and iodine maps (IMs) as a potentially efficient search series for routine clinical imaging in patients with hypervascular abdominal tumors. Methods: A total of 69 patients with hypervascular abdominal tumors including neuroendocrine neoplasms (NENs, n = 48), renal cell carcinoma (RCC, n = 10), and primary hepatocellular carcinoma (HCC, n = 11) were analyzed retrospectively. Two radiological readers (blinded to clinical data) read three CT image sets (1st a reference set with 70 keV; 2nd a 50:50 hybrid 140 keV/40 keV set; 3rd a 50:50 hybrid 140 keV/IM set). They assessed images subjectively by rating several parameters including image contrast, visibility of suspicious lesions, and diagnostic confidence on five-point Likert scales. In addition, reading time was estimated. Results: Median subjective Likert scores were highest for the 1st set, except for image contrast, for which the 2nd set was rated highest. Scores for diagnostic confidence, artifacts, noise, and visibility of suspicious lesions or small structures were significantly higher for the 1st set than for the 2nd or 3rd set (p < 0.001). Regarding image contrast, the 2nd set was rated significantly higher than the 3rd set (p < 0.001), while the median did not differ significantly compared with the 1st set. Agreement between the two readers was high for all sets. Estimated potential reading time was the same for hybrid and reference sets. Conclusions: Hybrid images have the potential to efficiently exploit the additional information provided by SCT in patients with hypervascular abdominal tumors. However, the use of rigid weighting did not significantly improve diagnostic performance in this study.
- 25 August 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (9) , 1539
Open AccessSpectral CT Hybrid Images in the Diagnostic Evaluation of Hypervascular Abdominal Tumors—Potential Advantages in Clinical Routine
Background: This study aimed to investigate the use of spectral computed tomography (SCT) hybrid images combining virtual monoenergetic images (VMIs) and iodine maps (IMs) as a potentially efficient search series for routine clinical imaging in patients with hypervascular abdominal tumors. Methods: A total of 69 patients with hypervascular abdominal tumors including neuroendocrine neoplasms (NENs, n = 48), renal cell carcinoma (RCC, n = 10), and primary hepatocellular carcinoma (HCC, n = 11) were analyzed retrospectively. Two radiological readers (blinded to clinical data) read three CT image sets (1st a reference set with 70 keV; 2nd a 50:50 hybrid 140 keV/40 keV set; 3rd a 50:50 hybrid 140 keV/IM set). They assessed images subjectively by rating several parameters including image contrast, visibility of suspicious lesions, and diagnostic confidence on five-point Likert scales. In addition, reading time was estimated. Results: Median subjective Likert scores were highest for the 1st set, except for image contrast, for which the 2nd set was rated highest. Scores for diagnostic confidence, artifacts, noise, and visibility of suspicious lesions or small structures were significantly higher for the 1st set than for the 2nd or 3rd set (p < 0.001). Regarding image contrast, the 2nd set was rated significantly higher than the 3rd set (p < 0.001), while the median did not differ significantly compared with the 1st set. Agreement between the two readers was high for all sets. Estimated potential reading time was the same for hybrid and reference sets. Conclusions: Hybrid images have the potential to efficiently exploit the additional information provided by SCT in patients with hypervascular abdominal tumors. However, the use of rigid weighting did not significantly improve diagnostic performance in this study.
- Open Access
- 1 August 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 1877-1886
Quantitative CT Analysis in Patients with Pulmonary Emphysema: Do Calculated Differences Between Full Inspiration and Expiration Correlate with Lung Function?
Purpose: The aim of this retrospective study was to evaluate correlations between parameters of quantitative computed tomography (QCT) analysis, especially the 15th percentile of lung attenuation (P15), and parameters of clinical tests in a large group of patients with pulmonary emphysema. Patients and Methods: One hundred and seventy-two patients with pulmonary emphysema and chronic obstructive pulmonary disease (COPD) global initiative for chronic obstructive lung disease (GOLD) stage 3 or 4 were assessed by nonenhanced thin-section CT scans in full inspiratory and expiratory breath-hold, pulmonary function test (PFT), a 6-minute walk test (6MWT), and quality of life questionnaires (SGRQ and CAT). QCT parameters included total lung volume (TLV), total emphysema score (TES), and P15, all measured at inspiration (IN) and expiration (EX). Differences between inspiration and expiration were calculated for TLV (TLVDiff), TES (TESDiff), and P15 (P15Diff). Spearman correlation analysis was performed. Results: CT-measured lung volume in inspiration (TLVIN) correlated strongly with spirometry-measured total lung capacity (TLC) (r=0.81, p< 0.001) and moderately to strongly with residual volume (RV), forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1)/FVC (r=0.60, 0.56, and − 0.49, each p< 0.001). Lung volume in expiration (TLVEX) correlated moderately to strongly with TLC, RV and FEV1/FVC ratio (r=0.75, 0.66, and − 0.43, each p< 0.001). TES and P15 showed stronger correlations with the carbon monoxide transfer coefficient (KCO%) (r= − 0.42, 0.44, both p< 0.001), when measured during expiration. P15Diff correlated moderately with KCO% and carbon monoxide diffusing capacity (DLCO%) (r= 0.41, 0.40, both p< 0.001). The 6MWT and most QCT parameters showed significant differences between COPD GOLD 3 and 4 groups. Conclusion: Our results suggest that QCT can help predict the severity of lung function decrease in patients with pulmonary emphysema and COPD GOLD 3 or 4. Some QCT parameters, including P15EX and P15Diff, correlated moderately to strongly with parameters of pulmonary function tests.
- 1 August 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 1877-1886
Open AccessQuantitative CT Analysis in Patients with Pulmonary Emphysema: Do Calculated Differences Between Full Inspiration and Expiration Correlate with Lung Function?
Purpose: The aim of this retrospective study was to evaluate correlations between parameters of quantitative computed tomography (QCT) analysis, especially the 15th percentile of lung attenuation (P15), and parameters of clinical tests in a large group of patients with pulmonary emphysema. Patients and Methods: One hundred and seventy-two patients with pulmonary emphysema and chronic obstructive pulmonary disease (COPD) global initiative for chronic obstructive lung disease (GOLD) stage 3 or 4 were assessed by nonenhanced thin-section CT scans in full inspiratory and expiratory breath-hold, pulmonary function test (PFT), a 6-minute walk test (6MWT), and quality of life questionnaires (SGRQ and CAT). QCT parameters included total lung volume (TLV), total emphysema score (TES), and P15, all measured at inspiration (IN) and expiration (EX). Differences between inspiration and expiration were calculated for TLV (TLVDiff), TES (TESDiff), and P15 (P15Diff). Spearman correlation analysis was performed. Results: CT-measured lung volume in inspiration (TLVIN) correlated strongly with spirometry-measured total lung capacity (TLC) (r=0.81, p< 0.001) and moderately to strongly with residual volume (RV), forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1)/FVC (r=0.60, 0.56, and − 0.49, each p< 0.001). Lung volume in expiration (TLVEX) correlated moderately to strongly with TLC, RV and FEV1/FVC ratio (r=0.75, 0.66, and − 0.43, each p< 0.001). TES and P15 showed stronger correlations with the carbon monoxide transfer coefficient (KCO%) (r= − 0.42, 0.44, both p< 0.001), when measured during expiration. P15Diff correlated moderately with KCO% and carbon monoxide diffusing capacity (DLCO%) (r= 0.41, 0.40, both p< 0.001). The 6MWT and most QCT parameters showed significant differences between COPD GOLD 3 and 4 groups. Conclusion: Our results suggest that QCT can help predict the severity of lung function decrease in patients with pulmonary emphysema and COPD GOLD 3 or 4. Some QCT parameters, including P15EX and P15Diff, correlated moderately to strongly with parameters of pulmonary function tests.
- 2 March 2020
- Published by SAGE Publications in Acta Radiologica
- Vol. 61 (10) , 1421-1430
Improvement of image quality and diagnostic confidence using Smart MAR – a projection-based CT protocol in patients with orthopedic metallic implants in hip, spine, and shoulder
In computed tomography (CT) scans, artifacts caused by metallic orthopedic implants still hamper the visualization of important, periprosthetic tissues. Smart MAR metal artifact reduction tool is a promising three-stage, projection-based, post-processing algorithm. To determine whether the Smart MAR tool improves subjective and objective image quality and diagnostic confidence in patients with orthopedic implants of the hip, spine, and shoulder. Seventy-two patients with orthopedic screws, hip/shoulder replacement, or spine spondylodesis were included. CT scans were performed on a single-source multislice CT scanner, raw data were post-processed using Smart MAR. Image quality was evaluated both quantitatively (ROI-based) and qualitatively (rater-based) and compared to iterative reconstructions (ASIR V). As comparative standard for artificial prosthetic breaks or loosening, follow-up examinations were used. Smart MAR reconstructions of the hip (n = 23), spine (n = 26), and shoulder (n = 23) showed a significantly reduced attenuation and noise of regions adjacent to metallic implants (PPP = 0.038/P = 0.046) and overall diagnostic confidence were higher in Smart MAR (all regions PP = 0.72/P = 0.96) was not improved. Compared to standard ASIR V new, artificial metal extinctions (up to 50%) or periprosthetic hem lines (48%–73%) were introduced by Smart MAR. Smart MAR improved image quality of the hip, spine, and shoulder CT scans resulting in higher diagnostic confidence in evaluation of periprosthetic soft tissues. As shown for spine implants, it should be used with caution and as a complementary tool for evaluation of periprosthetic loosening or integrity of metal implant, as in many cases it introduced new artifacts.
- 2 March 2020
- Published by SAGE Publications in Acta Radiologica
- Vol. 61 (10) , 1421-1430
Improvement of image quality and diagnostic confidence using Smart MAR – a projection-based CT protocol in patients with orthopedic metallic implants in hip, spine, and shoulder
In computed tomography (CT) scans, artifacts caused by metallic orthopedic implants still hamper the visualization of important, periprosthetic tissues. Smart MAR metal artifact reduction tool is a promising three-stage, projection-based, post-processing algorithm. To determine whether the Smart MAR tool improves subjective and objective image quality and diagnostic confidence in patients with orthopedic implants of the hip, spine, and shoulder. Seventy-two patients with orthopedic screws, hip/shoulder replacement, or spine spondylodesis were included. CT scans were performed on a single-source multislice CT scanner, raw data were post-processed using Smart MAR. Image quality was evaluated both quantitatively (ROI-based) and qualitatively (rater-based) and compared to iterative reconstructions (ASIR V). As comparative standard for artificial prosthetic breaks or loosening, follow-up examinations were used. Smart MAR reconstructions of the hip (n = 23), spine (n = 26), and shoulder (n = 23) showed a significantly reduced attenuation and noise of regions adjacent to metallic implants (PPP = 0.038/P = 0.046) and overall diagnostic confidence were higher in Smart MAR (all regions PP = 0.72/P = 0.96) was not improved. Compared to standard ASIR V new, artificial metal extinctions (up to 50%) or periprosthetic hem lines (48%–73%) were introduced by Smart MAR. Smart MAR improved image quality of the hip, spine, and shoulder CT scans resulting in higher diagnostic confidence in evaluation of periprosthetic soft tissues. As shown for spine implants, it should be used with caution and as a complementary tool for evaluation of periprosthetic loosening or integrity of metal implant, as in many cases it introduced new artifacts.
- 8 July 2019
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 63 (5) , 641-649
Tumour response in non‐small‐cell lung cancer patients treated with chemoradiotherapy – Can spectral CT predict recurrence?
Introduction: Tumour response in lung cancer treatment is monitored by measuring lesion size in computed tomography (CT). Spectral CT (SCT) offers additional information on tumour tissue besides morphology. We evaluated SCT iodine content (IC) and performed spectral slope analysis to assess the response of non‐small‐cell lung cancer (NSCLC) to chemoradiotherapy (CRT).Methods: Eighty‐three patients with advanced NSCLC treated by CRT prospectively underwent single‐phase, contrast‐enhanced SCT. Evaluation of all patients included treatment response (RECIST 1.1), quantitative measurements as well as SCT IC determination and spectral slope analysis in NSCLC primaries. Measurements were performed at the maximum cross‐diameter of tumours and in areas with high iodine values (hotspot analysis). Iodine difference (ΔIC) was calculated. Secondary outcome parameters were IC and spectral slopes in mediastinal lymph nodes (n = 61).Results: Twenty‐four patients (29%) showed complete remission after CRT. Thirty‐four patients (41%) had stable disease (SDSCT) or partial regression (PRSCT). Progressive disease (PDSCT) was seen in 25 patients (30%). Hotspot analysis showed significantly higher iodine values in PDSCT than in SDSCT/PRSCT (P < 0.001). Ten patients (12%) with initially stable disease in SCT showed progressive disease during follow‐up for up to 18 months (PDFU). These patients also had significantly higher hotspot iodine values and ΔIC in the initial scan compared to patients with SD throughout the follow‐up period (SDFU) (29%) (P < 0.001). Enlarged lymph nodes showed significantly lower iodine content and a lower spectral slope pitch than normal‐sized nodes (P = 0.003 to 0.029).Conclusion: Spectral CT‐derived iodine content of NSCLC following CRT may help in predicting recurrence. Hotspot analysis and iodine heterogeneity allow the identification of residual vascularisation as an indicator of vital tumour tissue, indicating that IC might be a suitable imaging biomarker for predicting tumour progression. Iodine content and spectral slope analysis might also help in identifying metastatic lymph nodes.
- 8 July 2019
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 63 (5) , 641-649
Tumour response in non‐small‐cell lung cancer patients treated with chemoradiotherapy – Can spectral CT predict recurrence?
Introduction: Tumour response in lung cancer treatment is monitored by measuring lesion size in computed tomography (CT). Spectral CT (SCT) offers additional information on tumour tissue besides morphology. We evaluated SCT iodine content (IC) and performed spectral slope analysis to assess the response of non‐small‐cell lung cancer (NSCLC) to chemoradiotherapy (CRT).Methods: Eighty‐three patients with advanced NSCLC treated by CRT prospectively underwent single‐phase, contrast‐enhanced SCT. Evaluation of all patients included treatment response (RECIST 1.1), quantitative measurements as well as SCT IC determination and spectral slope analysis in NSCLC primaries. Measurements were performed at the maximum cross‐diameter of tumours and in areas with high iodine values (hotspot analysis). Iodine difference (ΔIC) was calculated. Secondary outcome parameters were IC and spectral slopes in mediastinal lymph nodes (n = 61).Results: Twenty‐four patients (29%) showed complete remission after CRT. Thirty‐four patients (41%) had stable disease (SDSCT) or partial regression (PRSCT). Progressive disease (PDSCT) was seen in 25 patients (30%). Hotspot analysis showed significantly higher iodine values in PDSCT than in SDSCT/PRSCT (P < 0.001). Ten patients (12%) with initially stable disease in SCT showed progressive disease during follow‐up for up to 18 months (PDFU). These patients also had significantly higher hotspot iodine values and ΔIC in the initial scan compared to patients with SD throughout the follow‐up period (SDFU) (29%) (P < 0.001). Enlarged lymph nodes showed significantly lower iodine content and a lower spectral slope pitch than normal‐sized nodes (P = 0.003 to 0.029).Conclusion: Spectral CT‐derived iodine content of NSCLC following CRT may help in predicting recurrence. Hotspot analysis and iodine heterogeneity allow the identification of residual vascularisation as an indicator of vital tumour tissue, indicating that IC might be a suitable imaging biomarker for predicting tumour progression. Iodine content and spectral slope analysis might also help in identifying metastatic lymph nodes.
- Open Access
- 1 July 2019
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 14, 1583-1593
Quantitative CT analysis in patients with pulmonary emphysema: is lung function influenced by concomitant unspecific pulmonary fibrosis?
Purpose: Quantitative analysis of CT scans has proven to be a reproducible technique, which might help to understand the pathophysiology of chronic obstructive pulmonary disease (COPD) and combined pulmonary fibrosis and emphysema. The aim of this retrospective study was to find out if the lung function of patients with COPD with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages III or IV and pulmonary emphysema is measurably influenced by high attenuation areas as a correlate of concomitant unspecific fibrotic changes of lung parenchyma. Patients and methods: Eighty-eight patients with COPD GOLD stage III or IV underwent CT and pulmonary function tests. Quantitative CT analysis was performed to determine low attenuation volume (LAV) and high attenuation volume (HAV), which are considered to be equivalents of fibrotic (HAV) and emphysematous (LAV) changes of lung parenchyma. Both parameters were determined for the whole lung, as well as peripheral and central lung areas only. Multivariate regression analysis was used to correlate HAV with different parameters of lung function. Results: Unlike LAV, HAV did not show significant correlation with parameters of lung function. Even in patients with a relatively high HAV of more than 10%, in contrast to HAV (p=0.786) only LAV showed a significantly negative correlation with forced expiratory volume in 1 second (r=−0.309, R2=0.096, p=0.003). A severe decrease of DLCO% was associated with both larger HAV (p=0.045) and larger LAV (p=0.001). Residual volume and FVC were not influenced by LAV or HAV. Conclusion: In patients with COPD GOLD stage III-IV, emphysematous changes of lung parenchyma seem to have such a strong influence on lung function, which is a possible effect of concomitant unspecific fibrosis is overwhelmed.
- 1 July 2019
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 14, 1583-1593
Open AccessQuantitative CT analysis in patients with pulmonary emphysema: is lung function influenced by concomitant unspecific pulmonary fibrosis?
Purpose: Quantitative analysis of CT scans has proven to be a reproducible technique, which might help to understand the pathophysiology of chronic obstructive pulmonary disease (COPD) and combined pulmonary fibrosis and emphysema. The aim of this retrospective study was to find out if the lung function of patients with COPD with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages III or IV and pulmonary emphysema is measurably influenced by high attenuation areas as a correlate of concomitant unspecific fibrotic changes of lung parenchyma. Patients and methods: Eighty-eight patients with COPD GOLD stage III or IV underwent CT and pulmonary function tests. Quantitative CT analysis was performed to determine low attenuation volume (LAV) and high attenuation volume (HAV), which are considered to be equivalents of fibrotic (HAV) and emphysematous (LAV) changes of lung parenchyma. Both parameters were determined for the whole lung, as well as peripheral and central lung areas only. Multivariate regression analysis was used to correlate HAV with different parameters of lung function. Results: Unlike LAV, HAV did not show significant correlation with parameters of lung function. Even in patients with a relatively high HAV of more than 10%, in contrast to HAV (p=0.786) only LAV showed a significantly negative correlation with forced expiratory volume in 1 second (r=−0.309, R2=0.096, p=0.003). A severe decrease of DLCO% was associated with both larger HAV (p=0.045) and larger LAV (p=0.001). Residual volume and FVC were not influenced by LAV or HAV. Conclusion: In patients with COPD GOLD stage III-IV, emphysematous changes of lung parenchyma seem to have such a strong influence on lung function, which is a possible effect of concomitant unspecific fibrosis is overwhelmed.
- 5 July 2018
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 191 (02) , 137-138
Spontanes Pneumoperikard bei transdiaphragmaler Magenulcus-Perforation auf Grundlage einer Post-Transplantations-lymphoproliferativen Erkrankung (PTLD) der Magenwand
Ursächlich für ein Pneumoperikard sind meist penetrierende, seltener stumpfe Thoraxtraumen. Im Rahmen von Barotraumen, postoperativ, bei einliegenden perikardialen Drainagesystemen oder im Rahmen einer Perikarditis mit gasbildenden Bakterien kann es ebenfalls zu perikardialen Lufteinschlüssen kommen. Außerdem können sich fistulöse Prozesse zum Perikard ausdehnen und zu perikardialen Lufteinschlüsse führen. In Abgrenzung zu einem Pneumomediastinum beschränken sich bei einem Pneumoperikard die Lufteinschlüsse auf den Herzbeutel; eine Lageänderung führt meist zu einer Umverteilung der Lufteinschlüsse. Bereits geringe perikardiale Luftvolumina können ein Spannungspneumoperikard bedingen. Magenperforationen präsentieren sich klinisch meist als akutes Abdomen und erfordern in der Regel eine sofortige chirurgische Intervention. Dem Magenulcus als häufigste Ursache einer Perforation liegen ursächlich meist chronische Gastritiden aufgrund einer Magenschleimhautbesiedlung mit H. pylori zugrunde. Ulcera können zudem stressbedingt, medikamentös bedingt oder assoziiert mit selteneren Erkrankungen wie dem Zollinger-Ellison-Syndrom oder Hyperparathyreoidismus auftreten (Fischbach A et al. Z Gastroenterol 2016; 54: 327 – 363). Außerdem können Ulcera auf Grundlage neoplastischer Magenwandprozesse zu einer Perforation führen. Komplikationen des Magenulcus sind Blutungen, Stenosierungen durch Narbenbildung oder bei freier Perforation in die Bauchhöhle die akute Peritonitis. Bei gedeckten Perforationen wird der Wanddefekt vom umgebenden Fettgewebe verschlossen. Seltener können sich die Wanddefekte auch fistulös in umgebende Organe ausbreiten.
- 5 July 2018
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 191 (02) , 137-138
Spontanes Pneumoperikard bei transdiaphragmaler Magenulcus-Perforation auf Grundlage einer Post-Transplantations-lymphoproliferativen Erkrankung (PTLD) der Magenwand
Ursächlich für ein Pneumoperikard sind meist penetrierende, seltener stumpfe Thoraxtraumen. Im Rahmen von Barotraumen, postoperativ, bei einliegenden perikardialen Drainagesystemen oder im Rahmen einer Perikarditis mit gasbildenden Bakterien kann es ebenfalls zu perikardialen Lufteinschlüssen kommen. Außerdem können sich fistulöse Prozesse zum Perikard ausdehnen und zu perikardialen Lufteinschlüsse führen. In Abgrenzung zu einem Pneumomediastinum beschränken sich bei einem Pneumoperikard die Lufteinschlüsse auf den Herzbeutel; eine Lageänderung führt meist zu einer Umverteilung der Lufteinschlüsse. Bereits geringe perikardiale Luftvolumina können ein Spannungspneumoperikard bedingen. Magenperforationen präsentieren sich klinisch meist als akutes Abdomen und erfordern in der Regel eine sofortige chirurgische Intervention. Dem Magenulcus als häufigste Ursache einer Perforation liegen ursächlich meist chronische Gastritiden aufgrund einer Magenschleimhautbesiedlung mit H. pylori zugrunde. Ulcera können zudem stressbedingt, medikamentös bedingt oder assoziiert mit selteneren Erkrankungen wie dem Zollinger-Ellison-Syndrom oder Hyperparathyreoidismus auftreten (Fischbach A et al. Z Gastroenterol 2016; 54: 327 – 363). Außerdem können Ulcera auf Grundlage neoplastischer Magenwandprozesse zu einer Perforation führen. Komplikationen des Magenulcus sind Blutungen, Stenosierungen durch Narbenbildung oder bei freier Perforation in die Bauchhöhle die akute Peritonitis. Bei gedeckten Perforationen wird der Wanddefekt vom umgebenden Fettgewebe verschlossen. Seltener können sich die Wanddefekte auch fistulös in umgebende Organe ausbreiten.